Anna Berkenblit, a clinical oncologist and drug developer, was named the first-ever chief scientific and medical officer of the Pancreatic Cancer Action Network.
Diane M. Simeone will become director of Moores Cancer Center at UC San Diego Health effective April 1.
Tampa General Hospital was named an approved Center of Excellence facility for pancreatic cancer treatment by the National Pancreas Foundation.
FDA has approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil, and leucovorin, for the first-line treatment of metastatic pancreatic adenocarcinoma.
Edna “Eti” Cukierman was named the newly created Marvin & Concetta Greenberg Chair in Pancreatic Cancer Research at Fox Chase Cancer Center.
Edna “Eti” Cukierman, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute and co-leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently awarded the American Cancer Society’s Wilmott Family Professorship in Pancreatic Cancer.
Mark KelleyMelissa FishelMark Kelley and Melissa Fishel, two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, received a five-year, $2.4 million grant from NCI to explore therapies that target the critical pathways pancreatic tumors use to survive.
A study published in Journal of Personalized Medicine explores how oncology subspecialist reviews of pancreatic adenocarcinoma cases can identify care gaps and provide recommendations intended to improve treatment outcomes.
Researchers at Washington University School of Medicine in St. Louis received a Specialized Programs of Research Excellence, or SPORE, grant from NCI to support research and clinical trials aimed at improving therapies for pancreatic cancer.
Scientists at the Translational Genomics Research Institute, part of City of Hope, in collaboration with SIWA Therapeutics Inc., recently published results from a preclinical study that highlights the potential of SIWA318H, an advanced glycation end product-targeting antibody, for the treatment of pancreatic cancer.